KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Total Non-Current Liabilities (2016 - 2025)

Regeneron Pharmaceuticals has reported Total Non-Current Liabilities over the past 17 years, most recently at $7.3 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $7.3 billion for Q4 2025, up 6.56% from a year ago — trailing twelve months through Dec 2025 was $7.3 billion (up 6.56% YoY), and the annual figure for FY2025 was $7.3 billion, up 6.56%.
  • Total Non-Current Liabilities for Q4 2025 was $7.3 billion at Regeneron Pharmaceuticals, down from $7.3 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for REGN hit a ceiling of $7.3 billion in Q3 2025 and a floor of $5.2 billion in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $6.1 billion (2021), compared with a mean of $6.3 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 58.15% in 2021 and later dropped 8.91% in 2024.
  • Regeneron Pharmaceuticals' Total Non-Current Liabilities stood at $6.0 billion in 2021, then decreased by 1.22% to $5.9 billion in 2022, then rose by 5.76% to $6.3 billion in 2023, then rose by 9.3% to $6.8 billion in 2024, then rose by 6.56% to $7.3 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $7.3 billion (Q4 2025), $7.3 billion (Q3 2025), and $6.6 billion (Q2 2025) per Business Quant data.